03-Nov-2026 22:09:44
ARVEE LABORATORIES Q2 FY27 ; STANDALONE NET PROFIT UP 25208% AT ₹3 CR (YOY), UP 51% (QOQ)
REVENUE UP 622% AT ₹25 CR (YOY), UP 45% (QOQ) EBITDA UP 2592% AT ₹3 CR (YOY), UP 37% (QOQ) MARGINS AT 13.8% VS 3.7% (YOY), 14.5% (QOQ)
Latest market headlines for ARVEE on Terminal.
03-Nov-2026 22:09:44
REVENUE UP 622% AT ₹25 CR (YOY), UP 45% (QOQ) EBITDA UP 2592% AT ₹3 CR (YOY), UP 37% (QOQ) MARGINS AT 13.8% VS 3.7% (YOY), 14.5% (QOQ)